2024HOSPITALAR圓滿收官，熱景生物持續(xù)拓展海外朋友圈
2024-05-30
5月24日，巴西圣保羅國際醫(yī)療器械展覽會（Hospitalar）圓滿收官！
熱景生物的展位成為展會的焦點之一，并收獲了主辦方頒發(fā)的Better Stands銅獎。本次展會，熱景生物的化學(xué)發(fā)光和上轉(zhuǎn)發(fā)光免疫檢測解決方案，以及小分子免疫檢測新技術(shù)吸引了眾多參觀者的關(guān)注和贊譽(yù)。同時，公司還首次展出登革熱檢測產(chǎn)品，為熱帶地區(qū)傳染病診斷提供了新的解決方案。從高精度的診斷平臺，到高質(zhì)量診斷試劑和藥物原材料，熱景生物在各領(lǐng)域的技術(shù)優(yōu)勢和潛力獲得了與會各界的高度認(rèn)可。
持續(xù)深入了解客戶是熱景生物一貫的服務(wù)宗旨，也是企業(yè)不斷創(chuàng)新的動力源泉。本次展會中，我們不僅與現(xiàn)有客戶進(jìn)行深入交流，共同探索合作新機(jī)遇，還結(jié)識了許多新的潛在合作伙伴，持續(xù)拓展熱景海外朋友圈。
創(chuàng)新診斷，價值檢驗！熱景生物將繼續(xù)致力于研發(fā)創(chuàng)新解決方案，推動臨床檢測技術(shù)和實踐的發(fā)展和進(jìn)步，為構(gòu)建人類衛(wèi)生健康共同體貢獻(xiàn)更多中國力量。
On May 24th, 2024, the 2024 Brazil Sao Paulo International Medical Equipment Exhibition (Hospitalar) concluded successfully. In this expo, Hotgen's booth becomes one of the highlights of the exhibition, receiving Better Stands Bronze from the expo organizer,Informa. Hotgen’s versatile chemiluminescence and Up-Converting Phosphor Technology (patented) immunoassay solutions as well as the new diagnostic technology for small molecules receive many visitors’ attention and praise. At this exhibition, Hotgen’s dengue fever detection products makes its debut to the market, offering a new solution to tropic infectious disease diagnostics. From high-precision diagnostic platforms to high-quality diagnostic reagent raw materials, Hotgen’s technical advantages and potentials in various fields are well recognized.
Ever keeping communicating with customers for better understanding of their needs is always a key business principle of Hotgen, which continuously drives Hotgen's innovation since our foundation. During this exhibition, we not only had in-depth communication and interaction with existing customers in search of new cooperation opportunities, but also met many new potential partners, expanding Hotgen’s global relationship network.
Innovate diagnostics for value creation. Our commitment to innovative diagnostic solutions and medical laboratories development will sustain as always. We are looking forward to contributing more to the international healthcare community.
